Primary malignancy of the fallopian tube: A clinical review of 13 cases
β Scribed by George A. Johnston JR.
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 506 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Thirteen cases of primary fallopian tube cancer are presented from The Ohio State University Hospital. The majority of these tumors were diagnosed in the advanced stage of the disease with a considerable variety in histology for a small series.
The Pap smear was quite meaningful in the diagnosis of malignancy in three of the cases; however, none of these cases was diagnosed preoperatively as a tubal primary cancer per se. A careful consideration of the history of pain, vaginal discharge, and pelvic mass is most important in making this diagnosis of tubal cancer preoperatively, along with a high index of clinical suspicion.
In our experience, the stage of the disease was the single most important factor effecting patient survival. The mode of therapy appears to be a less important factor influencing survival. Patients treated with surgery and adjuvant chemotherapy had slightly better survival than did those patients in advanced stages treated by surgery and adjuvant radiation therapy.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Fallopian tube cancers are rare neoplasms. These malignancies are thought to behave biologically and clinically like ovarian cancer. The purpose of this study was to compare the clinical behavior and outcome of fallopian tube and ovarian cancer. ## METHODS. The Surveil
## Short -term cultures from a primary carcinoma of the Fallopian tube, a tumor type not characterized before by chromosome banding, were examined cytogenetically. Complex chromosome aberrations were found in all mitoses, yielding the karyotype 41,XX,del(I)(p34),de1(2)(q31),i(8)(qI0),-9,+dic(9;I9)
RIMARY malignant melanoma of the oral P cavity is an extremely rare tumor, but it may not be as uncommon as the number of reported cases would indicate. AfBeck8 reported an incidence of 0.4% among 317 cases of malignant melanoma; Baxter,l\* 0.6% among 170 cases; Hobaek,'O 1.2% among 269 cases; and A